Loading…
Reported covered position: covered legislative branch official
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ADAPTIVE BIOTECHNOLOGIES
H.R. 1946 and S. 1873- Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ADAPTIVE BIOTECHNOLOGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ADAPTIVE BIOTECHNOLOGIES via ADAPTIVE BIOTECHNOLOGIES
2022 · first_quarter · 1T
H.R. 1946 and S. 1873- Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022
Source: Senate LDA
Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ADAPTIVE BIOTECHNOLOGIES
H.R. 1946 and S. 1873- Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ADAPTIVE BIOTECHNOLOGIES
H.R. 1946 and S. 1873- Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ADAPTIVE BIOTECHNOLOGIES
Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022
Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022
Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ADAPTIVE BIOTECHNOLOGIES
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R.5745 - COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R.5745 - COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R.5745 - COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
H.R. 6102 and S.3404; The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020; all provisions
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
H.R. 6102 and S.3404; The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020; all provisions
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADAPTIVE BIOTECHNOLOGIES via ADAPTIVE BIOTECHNOLOGIES
2021 · fourth_quarter · Q4
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R.5745 - COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
Issues related to T-cells, COVID testing, and immune medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADAPTIVE BIOTECHNOLOGIES via ADAPTIVE BIOTECHNOLOGIES
2021 · third_quarter · Q3
Issues related to T-cells, COVID testing, and immune medicine
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADAPTIVE BIOTECHNOLOGIES via ADAPTIVE BIOTECHNOLOGIES
2021 · second_quarter · Q2
Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Issues related to T-cells, COVID testing, and immune medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADAPTIVE BIOTECHNOLOGIES via ADAPTIVE BIOTECHNOLOGIES
2021 · first_quarter · Q1
H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADAPTIVE BIOTECHNOLOGIES via ADAPTIVE BIOTECHNOLOGIES
2020 · fourth_quarter · Q4
H.R. 6102 and S.3404; The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020; all provisions
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADAPTIVE BIOTECHNOLOGIES via ADAPTIVE BIOTECHNOLOGIES
2020 · fourth_quarter · RR
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions
H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions